Literature DB >> 8082308

Expression of p75 chain of IL-2 receptor in the early immunological reconstitution after allogeneic bone marrow transplantation.

P Comoli1, R Maccario, D Montagna, M Labirio, M Zecca, R Clementi, F Bonetti, F Locatelli.   

Abstract

Expression of p55 and p75 chains of IL-2 receptor (IL-2R) on the surface of both T and natural killer (NK) circulating lymphocytes was investigated in 14 paediatric patients given allogeneic bone marrow transplantation (BMT) from HLA-identical sibling or partially matched family donors. IL-2-induced proliferative and cytotoxic responses were also studied and all analysis was performed within 45 days from transplant. We found that, early after transplant, the percentage of p55+ and of p75+ peripheral blood lymphocytes (PBL) was not significantly different in patients who had received HLA-identical BMT (p55+ 8.04 +/- 4.87%; p75+ 28.27 +/- 18.85%) compared with healthy controls (p55+ 7.26 +/- 6.17%; p75+ 19.42 +/- 10.49%), while recipients of T cell-depleted marrow included a remarkably high percentage (76-90%) of p75+ PBL, which were mostly CD3- and co-expressed CD56 molecule. Comparable values of p55+ lymphocytes were observed in all patients and controls. However, in contrast to the other two groups, in recipients of T cell-depleted BMT the majority of these cells co-expressed p75 chain and CD56 antigen. IL-2-induced proliferation and lymphokine-activated killer (LAK) activity were detectable in all patients, and their values did not correlate with expression of p55 or p75 chains. Our data suggest that expansion of NK subsets expressing IL-2R chains after T cell-depleted BMT may be related to early reconstitution of natural immunity in the presence of allogeneic stimuli.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082308      PMCID: PMC1534849          DOI: 10.1111/j.1365-2249.1994.tb06118.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction.

Authors:  R A Montgomery; M J Dallman
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

2.  THREE MAGNET CASES WITH SOME UNUSUAL FEATURES.

Authors:  I L Tuckett
Journal:  Br J Ophthalmol       Date:  1918-06       Impact factor: 4.638

Review 3.  Reconstruction of the haemopoietic and immune systems after marrow transplantation.

Authors:  K Atkinson
Journal:  Bone Marrow Transplant       Date:  1990-04       Impact factor: 5.483

4.  Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.

Authors:  S Rosenberg
Journal:  J Natl Cancer Inst       Date:  1985-10       Impact factor: 13.506

5.  Transient expression of IL-2 receptor precedes the differentiation of immature thymocytes.

Authors:  R P Shimonkevitz; L A Husmann; M J Bevan; I N Crispe
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

6.  Importance of IL-2 receptors in intra-thymic generation of cells expressing T-cell receptors.

Authors:  E J Jenkinson; R Kingston; J J Owen
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

7.  Differentiation of thymocytes in fetal organ culture: lack of evidence for the functional role of the interleukin 2 receptor expressed by prothymocytes.

Authors:  J Plum; M De Smedt
Journal:  Eur J Immunol       Date:  1988-05       Impact factor: 5.532

8.  Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2).

Authors:  E Ciccone; D Pende; O Viale; A Than; C Di Donato; A M Orengo; R Biassoni; S Verdiani; A Amoroso; A Moretta
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

9.  Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.

Authors:  E Lotzová; C A Savary; R B Herberman
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

10.  Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells.

Authors:  K Oshimi; Y Oshimi; M Akutsu; Y Takei; H Saito; M Okada; H Mizoguchi
Journal:  Blood       Date:  1986-10       Impact factor: 22.113

View more
  1 in total

1.  Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.

Authors:  Gloria Pelizzo; Veronica Veschi; Melissa Mantelli; Stefania Croce; Vincenzo Di Benedetto; Paolo D'Angelo; Alice Maltese; Laura Catenacci; Tiziana Apuzzo; Emanuela Scavo; Antonia Moretta; Matilde Todaro; Giorgio Stassi; Maria Antonietta Avanzini; Valeria Calcaterra
Journal:  BMC Cancer       Date:  2018-11-27       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.